This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
1 B Boucher , N Mannan , K Noonan , (1995) Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in East London Asians. Diabetologia 38, 1239–1245.
2 G Isaia , R Giorgino & S Adami (2001) High prevalence of hypovitaminosis D in female type 2 diabetic population. Diabetes Care 24, 1496.
3 JA Lucas , MJ Bolland , AB Grey , (2005) Determinants of vitamin D status in older women living in a subtropical climate. Osteoporos Int 16, 1641–1648.
4 R Scragg , I Holdaway , V Singh , (1995 b) Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus. Diabetes Res Clin Pract 27, 181–188.
5 C Mattila , P Knekt , S Mannisto , (2007) Serum 25-hyrdroxyvitamin D concentration and subsequent risk of type 2 diabetes. Diabetes Care 30, 2569–2570.
6 Z Maghbooli , A Hossein-Nezhad , F Karimi , (2008) Correlation between vitamin D3 deficiency and insulin resistance in pregnancy. Diabetes Metab Res Rev 24, 27–32.
7 R Alemzadeha , J Kichlerb , G Babara , (2008) Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season. Metabolism 57, 183–191.
8 NG Forouhi , Ja Luan , A Cooper , (2008) Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: The Medical Research Council Ely Prospective Study 1990–2000. Diabetes 57, 2619–2626.
9 S Kumar , M Davies & Y Zakaria (1994) Improvement in glucose tolerance and beta-cell function in a patient with vitamin D deficiency during treatment with vitamin D. Postgrad Med J 70, 440–443.
11 O Gedik & S Akalin (1986) Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man. Diabetologia 29, 142–145.
12 K Tai , AG Need , M Horowitz , (2008) Glucose tolerance and vitamin D: effects of treating vitamin D deficiency. Nutrition 24, 950–956.
13 J Nagpal , JN Pande & A Bhartia (2009) A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med 26, 19–27.
14 AG Pittas , J Lau , FB Hu , (2007) Review: the role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 92, 2017–2029.
20 PR Von Hurst , W Stonehouse , C Matthys , (2008) Metabolic syndrome, vitamin D and bone status in South Asian women living in Auckland, New Zealand: a randomised, placebo-controlled, double-blind vitamin D intervention. BMC Public Health 8, 1–8.
22 GM Reaven (2005) The insulin resistance syndrome: definition and dietary approaches to treatment. Annu Rev Nutr 25, 391–406.
23 DR Matthews , JP Hosker , AS Rudenski , (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412–419.
24 E Bonora , G Targher , M Alberiche , (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diabetes Care 23, 57–63.
25 T Wallace , J Levy & D Matthews (2004) Use and abuse of HOMA modelling. Diabetes Care 27, 1487–1495.
26 JC Levy , D Matthews & M Hermans (1998) Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21, 2191–2192.
27 R Sari , MK Balci , N Balci , (2007) Acute effect of exercise on plasma leptin level and insulin resistance in obese women with stable caloric intake. Endocr Res 32, 9–17.
29 V Chel , M Ooms & C Popp-Snijders (1998) Ultraviolet irradiation corrects vitamin D deficiency and suppresses secondary hyperparathyroidism in the elderly. J Bone Miner Res 13, 1238–1242.
30 A Taylor & P Wise (1998) Vitamin D replacement in Asians with diabetes may increase insulin resistance. Postgrad Med J 74, 365–366.
31 MJ Barger-Lux , RP Heaney , S Dowell , (1998) Vitamin D and its major metabolites: serum levels after graded oral dosing in healthy men. Osteoporos Int 8, 222.
33 C Cade & AW Norman (1986) Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo. Endocrinology 119, 84–90.
34 BS Chertow , WI Sivitz , NG Baranestsky , (1983) Cellular mechanisms of insulin release: the effects of vitamin D deficiency and repletion on rat insulin secretion. Endocrinology 113, 1511–1518.
37 S Weisberg , D McCann , M Desai , (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112, 1796–1808.
38 EE Kershaw & JS Flier (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89, 2548–2556.
40 K Muller , P Haahr , M Diamant , (1992) 1,25-dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level. Cytokine 4, 506–512.
41 M Canning , K Grotenhuis , Hd Wit , (2001) 1-Alpha, 25-dihydroxyvitamin D3 hampers the maturation of fully active immature dendritic cells from monocytes. Eur J Endocrinol 145, 351–357.
42 PM Timms , N Mannan , GA Hitman , (2002) Circulating MMP9, vitamin D and variation in the TIMP-1 response with VDR genotype: mechanisms for inflammatory damage in chronic disorders? QJM 95, 787–796.
43 A Kelley-Hedgepeth , DM Lloyd-Jones , A Colvin , (2008) Ethnic differences in C-reactive protein concentrations. Clin Chem 54, 1027–1037.
44 B Maestro , N Davila , MC Carranza , (2003) Identification of a vitamin D response element in the human insulin receptor gene promoter. J Steroid Biochem Mol Biol 84, 223–230.
45 B Maestro , J Campion , N Davila , (2000) Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J 47, 383–391.
46 B Maestro , S Molero , S Bajo , (2002) Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D3. Cell Biochem Funct 20, 227–232.
48 Y Kim , K Kotani , T Ciaraldi , (2003) Insulin-stimulated protein kinase C lambda/zeta activity is reduced in skeletal muscle of humans with obesity and type 2 diabetes. Diabetes 52, 1935–1942.